75N94024Q00018.Combined Synopsis Solicitation.pdf
PDF 185 KB Posted
- Attached to
- Acquisition of a BioQuantum Preventative Maintenance Plan Federal contract opportunity
- Solicitation number
- 75N94024Q00018
About this file
This combined synopsis/solicitation requests quotes for a preventative maintenance plan for a BioQuantum system owned by the National Institute of Diabetes and Digestive and Kidney Diseases. Quotes are due by January 31, 2024 for the firm fixed price plan covering the period from March 1, 2024 to May 24, 2027. The maintenance plan must be provided by GATAN, Inc., the manufacturer of the BioQuantum system, and include an annual preventive maintenance inspection, extended warranty, and priority field service support. The solicitation will be evaluated based on the vendor's ability to meet the specifications and pricing, with technical factors weighing more than price.
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
COMBINED SYNOPSIS / SOLICITATION WORKFORM
(1) Action Code: Combined Synopsis/Solicitation
(2) Date: 1/11/2024
(3) Year: 2024
(4) Contracting Office Zip Code: 20892
(5) Project Service Code: J066 – Maint/Repair/Rebuild of Equipment- Instruments And Laboratory
Equipment
(6) Contracting Office Address:
6710B Rockledge Drive Bethesda, MD 20892
(7) Subject/Title: Acquisition of a BioQuantum Preventative Maintenance Plan
(8) Proposed Solicitation Number: 75N94024Q00018
(9) Closing Response Date: 1/31/2024
(10) Contact Point: Amber Harris
(11) Contract Award and Solicitation Number: TBD
(12) Contract Award Dollar Amount: TBD
(13) Contract Line Item Number(s): TBD
(14) Contractor Award Date: TBD
(15) Contractor Name: TBD
(16) Description: (Background)
(i) “This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.”
(ii) The solicitation number is 75N94024Q00018 and the solicitation is issued as a request for quote (RFQ).
(iii) The solicitation document, the incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-06 Effective December 4, 2023.
(iv) The associated NAICS code is 811210, Electronic and Precision Equipment Repair and
Maintenance, and the small business size standard is $34.0. The acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.
(v) The Contractor Requirements are listed below:
1.0 PURCHASE ORDER TITLE
Acquisition of a BioQuantum Preventative Maintenance Plan
2.0 BACKGROUND
The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.
The NIDDK supports a wide range of medical research through grants to universities and other medical research institutions across the country. The Institute also supports government scientists who conduct basic, translational, and clinical research across a broad spectrum of research topics and serious, chronic diseases and conditions related to the Institute's mission. In addition, the NIDDK supports research training for students and scientists at various stages of their careers and a range of education and outreach programs to bring science-based information to patients and their families, health care professionals, and the public.
The Multi Institute Cryo-EM Facility (MICEF) is a collaborative facility maintained by the NIDDK. It serves the scientific communities of NHLBI, NIDDK and NINDS. MICEF currently houses a Titan Krios microscope equipped with GATAN, INC. BioQuantum K3 system.
MICEF offers support in planning EM experiments, sample preparation and imaging, using equipment, and analyzing data. To continue this support, the GATAN INC.
BioQuantum K3 system requires a preventative maintenance plan to keep the instrument functioning properly and providing accurate results.
3.0 OBJECTIVE
The objective of this requirement is to purchase a preventative maintenance plan for the GATAN, INC. BioQuantum system. The BioQuantum K3/GIF system is a complex, powerful and flexible imaging system equipped on Titan Krios electron microscope for 2D and 3D characterization of biological samples. To ensure the optimal thermal and mechanical stability and perfect optical performance, this imaging system requires regular maintenance. Maintaining the BioQuantum is essential for the system to continue producing high-quality Cryo-EM images. The BioQuantum system performs 24/7 and requires unattended operation.
4.0 SALIENT / REQUIRED FEATURES AND SPECIFICATIONS
The objective of this requirement is to purchase a preventative maintenance plan for the GATAN, INC. BioQuantum system. GATAN, INC. is the manufacturer of the BioQuantum imaging system and offers the only factory trained service organization that is qualified to service this product. GATAN, INC. maintenance representatives are trained and certified to maintain the distinctive hardware and software configurations for the BioQuantum system components. No other vendor will be able to provide the high level of specified maintenance and/or repairs to keep the BioQuantum system functioning at optimum levels. Failure to use GATAN, INC. to service the system and its many components may result in voiding any manufacturer warranties on the BioQuantum system, delays for software upgrades and repairs, and could result in inaccurate research results that in turn could result in MICEF’s failure to meet its mission.
The service(s) required will require unique skills and equipment. GATAN, INC. provides these skills and equipment, and based on past efforts, it has been determined they will be successful in meeting the challenges of this requirement. Furthermore, no other vendors are certified to provide maintenance to the BioQuantum system, except for the manufacturer. The manufacturer of the equipment does not authorize resellers, nor provide certifications to outside vendors to authorize them to service the specific
The Contractor shall adhere to the following:
Preventive Maintenance Plan:
• Unlimited telephone support
• Priority response for unscheduled field service
• Field-serviceable GATAN, INC. products under this contract type are allowed unlimited onsite visits per year.
• No charge for GATAN, INC.-manufactured replacement parts
• Discounts on spares and certain consumable parts
• An annual preventive maintenance session, including Repair, Maintenance, Calibration
Task Areas:
Task Area 1 – The vendor will perform one annual preventive maintenance inspection.
Task Area 2 – The vendor will provide an extended warranty, labor, and materials plan.
5.0 PURCHASE ORDER TYPE
This Purchase Order is to be a firm fixed price.
6.0 PERIOD OF PERFORMANCE AND PAYMENT BREAKDOWN
Base Year: 3/1/2024 - 2/28/2025 Option Year 1: 3/1/2025 - 2/28/2026 Option Year 2: 3/1/2026 - 5/24/2027
7.0 INSPECTION AND ACCEPTANCE
The Project Officer or the Project Officer Supervisor will perform inspection and acceptance of materials and services to be provided. For equipment orders, inspection and acceptance will be done AFTER All materials are unpacked, installed, and test run for operation. Receiving will be completed no later than 7 days following date of Delivery.
Acceptance and Delivery will be complete once the signed packing slip is provided to the
Vendor.
Inspection and acceptance will be performed at the place of installation –
The National Institutes of Health, NIDDK, Bldg. 13, Room G826, 9000 Rockville Pike, Bethesda, Maryland 20892.
For services, invoices will be approved by the Project officer and or COR according to payment terms in the resultant purchase order.
(vi) This is a competitive requirement being pursued through the authority granted in FAR 52.211-6, Brand Name or Equal. This is a requirement for a GATAN, INC. BioQuantum Preventative Maintenance Plan.
(vii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition.
(viii) The provision at FAR clause 52.212-2, Evaluation – Commercial Items, is applicable.
Award will be made to the contractor providing the most advantageous quote to the Government. Technical factors and price considered with technical factors outweighing price.
Specifically, the following technical factors will be evaluated:
i. The vendor will be evaluated on their quoted product meeting the specifications under section 4.0 SALIENT / REQUIRED FEATURES AND SPECIFICATIONS.
ii. The Offeror should note that the evaluation criteria listed in order of importance are:
A. Technical – The services proposed by the vendor meets the requirements in the SOW
B. Cost/Price
The technical factors are as follows:
The evaluation will be based on the demonstrated capabilities of the prospective Offeror in relation to the needs of the project as set forth in the Statement of Work. The merits of the proposal will be evaluated carefully and will be deemed Acceptable or Unacceptable. The proposal must document the feasibility of successful implementation of the requirements of the Statement of Work. The Offeror must submit information sufficient to evaluate the proposal based on the detailed factors listed in section 4.0 SALIENT / REQUIRED FEATURES AND
SPECIFICATIONS.
Evaluation Criteria Acceptable Unacceptable
Technical The services proposed by the vendor meet the requirements in the SOW
Summary Overall Rating (Overall Risk)
Cost/Price Offerors will be evaluated based upon cost/price completeness and accuracy to determine the validity of the price, realism, reasonableness, and risk.
Technical Evaluation Rating Definitions
(ix) FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, is applicable. An offeror shall complete only paragraphs (b) of this provision if the offeror has completed the annual representations and certificates electronically via http://www.acquisition.gov If an offeror has not completed the annual representations and certifications electronically at the System for Award Management (SAM) website, the offeror shall complete only paragraphs (c) through (p) of this provision.
(x) FAR clause at 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition.
(xi) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. Including the following clauses and Prohibitions:
i. 52.204-10, Reporting Executive Compensation and First-Tier
Subcontract Awards
ii. 52.209-6, Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment
iii. 52.219-4, Notice of Price Evaluation Preference for HUBZone Small
Business Concerns
iv. 52.219-28, Post Award Small Business Program Representation
v. 52.222-19, Child Labor—Cooperation with Authorities and Remedies
vi. 52.222-21, Prohibition of Segregated Facilities
vii. 52.222-26, Equal Opportunity
viii. 52.222-36, Equal Opportunity for Workers with Disabilities
ix. 52.222-50 Combating Trafficking in Persons
x. 52.223-18, Encouraging Contractor Policies to Ban Text Messaging while Driving
xi. 52.225-13, Restrictions on Certain Foreign Purchases
Rating Definition Acceptable Proposal meets requirements and indicates an adequate approach and understanding of the requirements, and risk of unsuccessful performance is no worse than moderate.
Unacceptable Proposal does not meet requirements of the solicitation, and thus, contains one or more deficiencies, and/or risk of unsuccessful performance is unacceptable.
http://www.acquisition.gov/
Additional Clauses:
i. 52.211-6 Brand Name or Equal
ii. 52.222-41, Service Contract Labor Standards
iii. 52.232-29, Terms for Financing of Purchases of Commercial Items
iv. 52.232-33, Payment by Electronic Funds Transfer— System for Award
Management
v. 52.232-39, Unenforceability of Unauthorized Obligations
(xii) Additional Contract Requirements:
The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required.
One (1) copy of the response is required and must be in Microsoft Word or Adobe
PDF format using 11- point or 12-point font, 8-1/2" x 11" paper size, with 1" top, bottom, left and right margins, and with single or double spacing. The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested.
Vendor/Contractor Must be able to accept payments via IPP (Invoice Processing
Platform) The contractor may submit a request for an exception. See below for IPP, IPP helpdesk information and applicable Health and Human Services addendum clause.
INVOICING PROCESSING PLATFORM (IPP) In compliance with the Office of
Management and Budget (OMB) M-15-19 memorandum "Improving Government Efficiency and Saving Taxpayer Dollars through Electronic Invoicing" directing Federal agencies to adopt electronic invoicing as the primary means to disburse payment to vendors. Invoices submitted under any award resulting from this solicitation will be required to utilize the Invoice Processing Platform (IPP) in accordance with HHSAR 352.232-71, Electronic Submission and Processing of Payment Requests" IPP is a secure, web-based electronic invoicing system provided by the U.S. Department of the Treasury's Bureau of the Fiscal Service, in partnership with the Federal Reserve Bank of St. Louis (FRSTL). Respondents to this solicitation are encouraged to register an account with IPP if they have not already done so. If your organization is already registered to use IPP, you will not be required to re-register however, we encourage you make sure your organization and designated IPP user accounts are valid and up to date. The IPP website address is:
https://www.ipp.gov If you require assistance registering or IPP account access, please contact the IPP Helpdesk at (866) 973-3131 (M-F 8AM to 6PM ET), or IPPCustomerSupport@fiscal.treasury.gov Note: Should an Offeror feel that use of the IPP would be unduly burdensome, the response to this solicitation should include an explanation of this position for a determination by the contracting officer.
HHSAR 352.232-71 Electronic Submission of Invoice Payment Requests (Feb 2022) will apply when this requirement is solicited and awarded. As stated: (a) Definitions.
As used in this clause, Payment request means a bill, voucher, invoice, or request for contract financing payment with associated supporting documentation. The payment request must comply with the requirements identified in FAR 32.905(b), "Content of Invoices" and the applicable Payment clause included in this contract. (b) Except as provided in paragraph (c) of this clause, the Contractor shall submit payment requests electronically using the Department of Treasury Invoice Processing Platform (IPP) or successor system. Information regarding IPP, including IPP Customer Support contact information, is available at www.ipp.gov or any successor site. (c) The Contractor may submit payment requests using other than IPP only when the Contracting Officer authorizes alternate procedures in writing in accordance with HHS procedures. (d) If alternate payment procedures are authorized, the Contractor shall include a copy of the Contracting Officer's written authorization with each payment request. (END OF CLAUSE)
(xiii) The Defense Priorities and Allocations System (DPAS) and assigned rating are not applicable.
(xiv) Offers shall be submitted via email to amber.harris@nih.gov and must reference 75N94024Q00018 in the subject line.
(17) Place of Contract Performance:
National Institute of Health, NIDDK 10 Center Drive Bethesda MD 20892
(18) Set-aside Status: This requirement is not set aside for small business.
mailto:amber.harris@nih.gov
File details come from the government source that posted it. Updated .